Updated: Jun 10, 2020
The world's first integrated 3D bioprinter + confocal scanner (BioAssemblyBot + GE IN Cell Analyzer 6500HS)
Strategic R&D and distribution partnership aims to advance the field of 3D biofabrication.
Printed cells with vascularization would be first step toward more complex biological structures for bone, soft tissue, and organ replacements.
The partners will create an integrated and agile way to print cells using cellular imaging and six-axis digital biofabrication.
MARLBOROUGH, MA. and LOUISVILLE, KY. – December 8, 2019 – GE Healthcare Life Sciences and Advanced Solutions Life Sciences (ASLS) will enter into a strategic R&D and distribution partnership that sets out to personalize tissue regeneration. The integration of IN Cell Analyzer and BioAssemblyBot® systems technologies will embed cellular-level assessments into the 3D-bioprinting workflow used to create human tissue models.